News
News-Medical.Net on MSN14h
Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists
Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
Zacks Investment Research on MSN3h
Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?
Amgen AMGN and Novo Nordisk NVO are among the largest companies in the pharmaceutical space. Amgen boasts one of the largest ...
In the second part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, explains how dual-action metabolic therapies can address clinical or tolerability gaps observed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback